InsiderSignal.AI

InsiderSignal.ai

CVM - Cel Sci Corp

Insider Purchase by Kersten Geert R (CEO)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Kersten Geert R, serving as CEO at Cel Sci Corp (CVM), purchased 38,023 shares at $5.26 per share, for a total transaction value of $200,001.00. Following this transaction, Kersten Geert R now holds 120,815 shares of CVM.

This purchase represents a 46.00% increase in Kersten Geert R's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, January 22, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 26, 2026, 4 days after the trade was made.

Cel Sci Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Kersten Geert R

CEO

Geert R. Kersten, Esq. is the Chief Executive Officer (CEO), Treasurer, and a Director at CEL-SCI Corporation (CVM), a clinical-stage biotechnology company focused on cancer immunotherapy, particularly its lead product Multikine for head and neck cancer.[[1]](https://fintool.com/app/research/companies/CVM/people/geert-kersten)[[3]](https://cel-sci.com/about-us/)[[5]](https://en.wikipedia.org/wiki/Cel-Sci_Corporation) He has served in his current leadership role since 1995 and has been with CEL-SCI since its inception in 1987, leading financing, R&D efforts, and the company's Multikine strategy over nearly four decades.[[1]](https://fintool.com/app/research/companies/CVM/people/geert-kersten)[[2]](https://www.streetwisereports.com/pub/htdocs/expert.html?id=11563)[[3]](https://cel-sci.com/about-us/) Kersten holds an undergraduate degree in Accounting, an MBA from George Washington University, and a JD from American University, providing expertise in finance and law from prior roles at Finley & Kumble law firm and Source Capital investment banking.[[1]](https://fintool.com/app/research/companies/CVM/people/geert-kersten) As of 2025, he is approximately 66 years old and has recently engaged in insider trading at CVM, including a personal purchase of $200,000 worth of stock.[[1]](https://fintool.com/app/research/companies/CVM/people/geert-kersten)[[6]](https://www.youtube.com/watch?v=dJ6TFc5joy4) Under his leadership, CEL-SCI is pursuing global commercialization, including regulatory pathways in the U.S., Europe, and Saudi Arabia.[[6]](https://www.youtube.com/watch?v=dJ6TFc5joy4)

View full insider profile →

Trade Price

$5.26

Quantity

38,023

Total Value

$200,001.00

Shares Owned

120,815

Trade Date

Thursday, January 22, 2026

31 days ago

SEC Filing Date

Monday, January 26, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Cel Sci Corp

Company Overview

No company information available
View news mentioning CVM

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3438035

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime